FATE THERAPEUTICS, INC. (FATE) Operating income 2016–2025
FATE THERAPEUTICS, INC. (FATE) annual operating income history from SEC filings — each fiscal year as reported.
-$147.7MFY2025 · since FY2016: -$32.0M → -$147.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$147.7M | +29.8% |
| FY2024 | -$210.3M | -10.4% |
| FY2023 | -$190.5M | +38.2% |
| FY2022 | -$308.4M | -42.1% |
| FY2021 | -$217.0M | -69.4% |
| FY2020 | -$128.1M | -27.2% |
| FY2019 | -$100.7M | -50.1% |
| FY2018 | -$67.1M | -59.3% |
| FY2017 | -$42.1M | -31.8% |
| FY2016 | -$32.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice